Sort
27,075 grants matching “cholesterol”
2/3-Improving Metabolic Parameters of Antipsychotic Child Treatment
$423,301Linmarie Sikich · Univ Of North Carolina Chapel Hill · R01 · FY2009 · MH
China Health and Retirement Longitudinal Study
$423,265Yaohui Zhao · Peking University · R01 · FY2012 · AG
DEFENSIN AND THE PATHOGENESIS OF ATHEROSCLEROSIS
$423,159University Of Pennsylvania · R01 · FY2001 · HL
Effects of particulate air pollution on HDL function and atherosclerosis
$423,146Jesus Antonio Araujo · University Of California Los Angeles · R01 · FY2011 · ES
Targeting tumor cell macrophage lipid interactions to overcome resistance to androgen receptor targeted therapy
$423,130Asmaa Elkenawi · Indiana University Indianapolis · R21 · FY2023 · CA
Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH
$422,934Laney K Jones · Geisinger Clinic · R61 · FY2022 · HL
Coxiella manipulation of cholesterol in the intracellular niche
$422,874Stacey D Gilk · University Of Nebraska Medical Center · R01 · FY2022 · AI
SREBP-Mediated Regulation of Intestinal Epithelial Homeostasis
$422,820Luke James Engelking · Ut Southwestern Medical Center · R01 · FY2021 · DK
SREBP-Mediated Regulation of Intestinal Epithelial Homeostasis
$422,820Luke James Engelking · Ut Southwestern Medical Center · R01 · FY2019 · DK
SREBP-Mediated Regulation of Intestinal Epithelial Homeostasis
$422,820Luke James Engelking · Ut Southwestern Medical Center · R01 · FY2023 · DK
SREBP-Mediated Regulation of Intestinal Epithelial Homeostasis
$422,820Luke James Engelking · Ut Southwestern Medical Center · R01 · FY2020 · DK
SREBP-Mediated Regulation of Intestinal Epithelial Homeostasis
$422,820Luke James Engelking · Ut Southwestern Medical Center · R01 · FY2022 · DK
THE CLINICAL EFFECTIVENESS OF PHARMACY ADHERENCE INFORMATION FOR DIABETES CONTROL
$422,800Manel Pladevall · Henry Ford Health System · R01 · FY2008 · DK
Therapeutic targeting and biophysical characterization of CAR-mediated trogocytosis
$422,799Tim Luetkens · University Of Maryland Baltimore · R21 · FY2025 · CA
Novel regulatory mechanisms controlling hepatic apoB-Lp lipid loading and secretion
$422,764Edward A Fisher · New York University D/B/A Nyu Long Island School Of Medicine · P01 · FY2025 · HL
Ligands and cofactors required for RORgt function in the immune system
$422,709Dan R Littman · New York University School Of Medicine · R01 · FY2009 · AI
Macrophage-lipoprotein Interactions
$422,617Frederick R. Maxfield · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · HL
Macrophage-lipoprotein Interactions
$422,617Frederick R. Maxfield · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · HL
NUTRITION AND LIPOPROTEIN METABOLISM IN ATHEROSCLEROSIS
$422,597Wake Forest University Health Sciences · R01 · FY2001 · HL
MicroRNAs as physiological and pathological regulators of cholesterol homeostasis
$422,500Kathryn J Moore · New York University School Of Medicine · R01 · FY2011 · HL
Efferocytosis meets endocytosis
$422,500Bishuang Cai · Icahn School Of Medicine At Mount Sinai · R35 · FY2024 · GM
From QTL to Gene for HDL Cholesterol
$422,500Jackson Laboratory · R01 · FY2005 · HL
Role of microRNAs in lipid metabolism and cardiovascular disease
$422,500Carlos Fernandez Hernando · New York University School Of Medicine · R01 · FY2011 · HL
Role of microRNAs in lipid metabolism and cardiovascular disease
$422,500Carlos Fernandez Hernando · New York University School Of Medicine · R01 · FY2012 · HL
From QTL to Gene for HDL Cholesterol
$422,500Jackson Laboratory · R01 · FY2004 · HL